Justia Intellectual Property Opinion Summaries

Y.Y.G.M. SA, doing business as Brandy Melville, manufactures its own clothing, home goods, and other items. It owns several trademarks, including the Brandy Melville Heart Mark (Heart Mark) and the LA Lightning Mark (Lightning Mark). Redbubble owns and operates an online marketplace where artists can upload their artwork to be printed on various products and sold. After a jury found that Redbubble, Inc. had violated Brandy Melville’s trademarks, the district court granted partial judgment as a matter of law to Redbubble on one trademark claim. Both parties appealed.   The Ninth Circuit affirmed in part and vacated in part the district court’s judgment after a jury trial in an action brought under the Lanham Act against Red Bubble. Vacating the district court’s order granting in part and denying in part Redbubble’s motion for judgment as a matter of law, the panel held that a party is liable for contributory infringement when it continues to supply its product to one whom it knows or has reason to know is engaging in trademark infringement. A party meets this standard if it is willfully blind to infringement. Agreeing with other circuits, the panel held that contributory trademark liability requires the defendant to have knowledge of specific infringers or instances of infringement. The panel held that, in granting judgment as a matter of law to Redbubble on the claim for contributory trademark counterfeiting as to the Heart Mark, the district court further erred by failing to evaluate the evidence of likelihood of confusion under the correct legal standard. View "Y.Y.G.M. SA V. REDBUBBLE, INC." on Justia Law

United Therapeutics holds New Drug Application (NDA) 022387 for Tyvaso®, an inhaled solution formulation of treprostinil approved for the treatment of pulmonary hypertension. It is a vasodilator that reduces vasoconstriction in the pulmonary vasculature, thereby decreasing blood pressure. United’s patents are listed in the FDA’s Orange Book for Tyvaso. Liquidia filed NDA 213005 for Yutrepia™ (21 U.S.C. 355(b)(2)), a dry powder inhalation formulation of treprostinil that is not a generic version of any currently marketed drug. United sued Liquidia, alleging infringement. Liquidia filed a petition for inter partes review (IPR); the Board found all claims of the 793 patent unpatentable as obvious. The district court concluded that seven claims of the 793 patent were not invalid and were infringed by Liquidia; several claims of the 066 patent were invalid as anticipated and would have been infringed by Liquidia but for the finding of anticipation; and claim 8 of the 066 patent was not invalid and not infringed.The Federal Circuit affirmed, upholding the district court’s determination that the meaning of “treating pulmonary hypertension” does not require a showing of safety and efficacy; the claims of the 793 patent are adequately enabled and supported by the written description; and Liquida induced infringement of that patent. View "United Therapeutics Corp. v. Liquidia Technologies, Inc." on Justia Law

Columbus-based financial advisors developed a financial product seemingly unique to the annuities market: the Transitions Beneficiary Income Rider, which would guarantee that, following a life insurance policyholder’s death, an insurance company would pay death-benefit proceeds to beneficiaries throughout their lifetimes. They founded Novus to launch the product. Novus contracted with Genesis and Annexus, financial product developers, to handle the eventual pitch to Novus’s target customer, Nationwide. Each agreement contained a confidentiality provision. Nationwide would not sign a nondisclosure agreement (NDA) and cautioned Novus not to disclose any confidential information about the Rider. An Annexus executive shared the Rider concept by email with Nationwide VP Morrone. Nationwide chose not to pursue the concept. After Novus’s unsuccessful pitch, Branch, Morrone’s supervisor, left Nationwide to join its competitor, Prudential. Branch convinced Ferris, also in Branch’s chain-of-command, and who had allegedly attended the in-person pitch, to leave Nationwide for Prudential. Prudential subsequently launched Legacy “eerily similar to” Rider.In Novus’s suit, alleging that Prudential engaged in trade secrets misappropriation, in violation of Ohio’s Uniform Trade Secrets Act, the district court granted summary judgment to Prudential. The Sixth Circuit affirmed. There is no reference to a confidential relationship through which Prudential acquired information about the Rider concept. View "Novus Group, LLC v. Prudential Financial, Inc." on Justia Law

Plaintiff claimed Defendant infringed her copyrights in two charts depicting organizational change. The key question is whether the copyright in one of those charts was registered with the Copyright Office such that it will support a suit for copyright infringement.The Ninth Circuit reversed the district court’s partial grant of summary judgment in favor of Defendants, vacated a jury verdict, vacated an award of attorneys’ fees, and remanded an action alleging infringement of copyrights in two charts depicting organizational change. The court held that Plaintiff created a genuine issue of material fact on that question. The panel held that Plaintiff raised a genuine dispute about whether she registered the chart directly or whether she registered elements of that chart by later registering an “Aligning for Success” chart. Agreeing with other circuits on a matter of first impression, the panel held that by registering a derivative work, an author registers all of the material included in the derivative work, including that which previously appeared in an unregistered, original work created by the author. The panel, therefore, reversed the district court’s grant of summary judgment and also vacated the jury verdict because, as a result of the grant of summary judgment, the district court prevented Plaintiff from introducing any evidence and making any argument as to the Managinwg Complex Change chart at trial. The panel further held that the district court erred in instructing the jury that if it found that Defendant accessed and copied other work but did not copy the registered Aligning for Success chart, then Dfendant’s challenged work was an independent creation. View "ENTERPRISE MANAGEMENT LIMITED, INC., ET AL V. CONSTRUX SOFTWARE BUILDERS, INC., ET AL" on Justia Law

Plaintiffs are photographers who sued Defendant Instagram for copyright infringement. Plaintiff alleged that Instagram violates their exclusive display right by permitting third-party sites to embed the photographers’ Instagram content. The district court held that Instagram could not be liable for secondary infringement because embedding a photo does not “display a copy” of the underlying images under Perfect 10.The Ninth Circuit affirmed the district court’s dismissal of an action brought by two photographers under the Copyright Act alleging that Instagram, LLC, violated their exclusive display right by permitting third-party sites to embed the photographers’ Instagram content. The panel held that, under Perfect 10 v. Amazon, 508 F.3d 1146 (9th Cir. 2007), Instagram could not be liable for secondary infringement because embedding a photo does not "display a copy" of the underlying image. Perfect 10 set forth the “Server Test,” which provides that a copy of a photographic image is not displayed when it is not fixed in a computer’s memory. The panel held that Perfect 10 did not restrict the application of the Server Test to a specific type of website, such as search engine. Arguments that Perfect10 is inconsistent with the Copyright Act are foreclosed by Perfect 10 outside of an en banc proceeding. And Perfect 10 was not effectively overturned by American Broadcasting Co. v. Aereo, 573 U.S. 431 (2014), which held that a streaming provider infringed broadcasters’ exclusive right to public performance. View "ALEXIS HUNLEY, ET AL V. INSTAGRAM, LLC" on Justia Law

Trinity sued Covalent for infringement of patent claims relating to methods and systems for connecting users based on their answers to polling questions. The Federal Circuit affirmed the dismissal of the suit, concluding that the asserted patents do not claim patentable subject matter under 35 U.S.C. 101. Because Trinity did not identify a proposed claim construction or specific facts to be discovered, the district court was not required to conduct claim construction and fact discovery before analyzing the asserted claims. The claims are directed to the abstract idea of matching based on questioning. A human mind could review people’s answers to questions and identify matches based on those answers; the patent’s requirements that the abstract idea be performed on a “hand-held device” or that matches are “reviewable by swiping” does not alter the conclusion that the focus of the asserted claims remains directed to an abstract idea, not an improvement on technology. The claims do not provide an inventive concept by virtue of their use of multiple processors, match servers, unique identifications, or a match aggregator. View "Trinity Info Media, LLC v. Covalent, Inc." on Justia Law

SNIPR's patents, directed to methods of selectively killing bacteria using CRISPR gene editing, claim priority to a 2016 Patent Cooperation Treaty (PCT) Application. Because their effective filing dates are after March 2013, they are pure America Invents Act (AIA) patents, examined and issued under first-inventor-to-file patentability requirements. The Rockefeller Application is also directed to selectively killing bacteria. It claims priority to a 2014 PCT Application and a February 2013 U.S. Provisional Application; it is a pure pre-AIA application.The Patent Board declared an interference to determine which party was the first to invent, then identified Rockefeller as the senior party, with an accorded benefit date of February 2013, and SNIPR as the junior party, with a May 2016 accorded benefit date (the date for which the Board recognizes that a patent application provides a proper constructive reduction to practice of the invention under pre-AIA 35 U.S.C. 102(g)(1)). SNIPR unsuccessfully moved to terminate, arguing that the AIA eliminated interferences for AIA patents. The Board reasoned that pre-AIA patent claims must “comply with [pre-AIA] 35 U.S.C. 102(g),” which requires an interference. SNIPR had not filed any priority statement asserting an invention date earlier than Rockefeller’s earliest accorded benefit date and failed to overcome Rockefeller’s senior party status. The Board canceled the SNIPR Patents.The Federal Circuit reversed. Pure AIA patents may not be part of an interference. SNIPR’s pure AIA patents were examined and issued under the AIA’s first-inventor-to-file patentability requirements and cannot be canceled under the pre-AIA invention priority requirements. View "SNIPR Technologies Ltd. v. Rockefeller University" on Justia Law

Float‘N’Grill's patent is directed to a float designed to support a grill to facilitate a user grilling food while remaining in a body of water. The specification describes a single embodiment. The apparatus includes a float and a pair of grill supports, each of which has a base rod, and an “inverted substantially U-shaped upper support medially attached to a top surface of the base rod.” Each of the supports “includes a plurality of magnets disposed within the middle segment of the upper support of each” grill support. After the patent was issued, FNG, believing that it claimed less than it was entitled to claim in the original patent, filed a reissue application, seeking claims that did not contain the narrow “plurality of magnets” limitation; the claims more generically call for the removable securing of a grill to the float apparatus.The Patent Trial and Appeal Board affirmed an Examiner’s rejections under 35 U.S.C. 112(b) and 251 of the 13 claims of the reissue application. The Federal Circuit affirmed. The reissue claims in question do not cover “the invention disclosed in the original patent” as required by 35 U.S.C. 251. The court did not address the indefiniteness of those claims under section 112(b). View "In Re Float‘N’Grill LLC" on Justia Law

The Medtronic patents describe and claim a neurostimulation lead and a method for implanting and anchoring the lead. Axonics, having been sued by Medtronic for infringement, challenged various claims of the Medtronic patents for obviousness in inter partes reviews (IPRs) under 35 U.S.C. 311–319. In both IPRs, the Patent Trial and Appeal Board concluded that Axonics had failed to prove any of the challenged claims unpatentable.The Federal Circuit vacated and remanded, The Board erred in its obviousness analysis and the errors cannot be regarded as harmless. Even if the Board was correct to treat the Medtronic patents as limited in the problem they address to the sacral-nerve context, it committed a fundamental legal error in confining the motivation inquiry to whether a motivation would exist to make the proposed combination for use in the specific trigeminal-nerve context—to which the Medtronic patents are not limited. The Board was also incorrect in its view that “the relevant art is medical leads specifically for sacral neuromodulation,” as the Medtronic patents’ claims are not limited to the sacral-nerve context; the shared specification, properly read, is not so limited either. View "Axonics, Inc. v. Medtronics, Inc." on Justia Law

Using a patent directed to a method for sorting sperm cells according to specific DNA characteristics to preselect the gender of a domestic animal’s offspring, STGenetics, provided bull semen-processing services to ABS, which sells semen drawn from its own bulls, packaged in small tubes for use in artificial insemination.In 2014, ABS filed an antitrust lawsuit, alleging that ST was maintaining monopoly power for sexed semen processing. ST brought counterclaims for trade secret misappropriation, breach of contract, and patent infringement. ABS stipulated to direct infringement of three claims. A jury awarded ST $750,000 for past infringement and a royalty on future sales of sexed semen tubes sold by ABS. The Seventh Circuit affirmed the validity findings and issued a remand that did not concern the ongoing royalty.ST filed another infringement suit, which was consolidated with the remand proceedings, then learned that ABS had begun selling and licensing ST’s system to third parties. ST filed a third suit, asserting induced infringement (35 U.S.C. 271(b)). The district court dismissed the action, citing claim preclusion.The Federal Circuit reversed. An induced patent infringement claim brought at the time of the first trial would have been based on speculation; the parties stipulated to direct infringement and the question of inducement was not before the jury. The scope of ABS’s direct infringement allegations cannot reasonably be expanded to cover actions of third-party licensees using the technology to make their own tubes. View "Inguran, LLC v. ABS Global, Inc." on Justia Law